As the development of vaccines or any drug will take time, research on Sars-CoV-2 neutralising antibodies is gaining ground to fill an unmet demand in therapy
from Latest News https://ift.tt/3cANjXw
Friday, 25 September 2020
Covid-19 fight: Indian companies join race to develop blood products
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment